Marinus Pharmaceuticals | Des Atouts



Des Atouts Changement Date
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
ALKERMES USD 2.33B 76.7M 2025-09
Amgen USD 90.59B 445M 2025-12
Biogen USD 29.44B 232M 2025-12
Eisai JPY 1.49T 48.22B 2025-12
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Esperion Therapeutics USD 364.02M 16.93M 2025-09
Gilead Sciences USD 59.02B 490M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Minerva Neurosciences USD 28.09M 2.33M 2025-09
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
PTC Therapeutics USD 2.64B 9.54M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Supernus Pharmaceuticals USD 1.42B 37.35M 2025-09
UCB EUR 17.35B 1.72B 2024-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12


Marinus Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.